Table 3.
Patient | Age at hearing test (years) | Gender (M/F) | Motor statusa | Respiratory functiona | Hearing loss (dB)a | |
---|---|---|---|---|---|---|
(right ear) | (left ear) | |||||
1 | 13.1 | M | Ambulant, prox weak | Normal | nh | nh |
2 | 6.0 | M | Ambulant, prox weak | Normal | 33.3 cond | nh |
3 | 12.7 | F | Ambulant, prox weak | Diminished | nh | nh |
4 | 11.9 | M | Partially wheelchair dep. | Normal | nh | nh |
5 | 12.7 | F | Tetraplegic | Invasive ventilation | 35 cond | 35 cond |
6 | 5.2 | M | Ambulant | Normal | nh | nh |
7 | 3 | M | Ambulant, prox weak | Normal | nh | nh |
8 | 16 | M | Ambulant | Diminished | nh | nh |
9 | 13 | M | Ambulant, prox weak | Diminished | nh | nh |
10 | 9 | F | Ambulant, prox weak | Normal | nh | nh |
11 | 15.2 | M | Ambulant, prox weak | Diminished, BIPAP | nh | nh |
12 | 16.4 | F | Paresis legs, scoliosis | Diminished, BIPAP | nh | nh |
13 | 9.2 | F | Partially wheelchair dep. | Diminished, BIPAP | nh | nh |
dB Decibels, nh normal hearing, cond conductive hearing loss, prox weak proximal weakness, BIPAP bi-level positive airway pressure
aBefore start of enzyme replacement therapy